SANTA CLARA, Calif., April 26, 2022 (GLOBE NEWSWIRE) — Minerva Surgical, Inc. (Nasdaq: UTRS), a women’s health company specializing in the treatment of AUB (abnormal uterine bleeding), today announced the launch first ever AUB Awareness Day on May 18, 2022.
The activation is designed to raise awareness of this common medical condition which affects 1 in 3 women and results in uterine bleeding outside of the normal volume, duration, regularity or frequency. AUB has a variety of causes and symptoms and can make a woman feel like life revolves around her period.
Dave Clapper, President and CEO of Minerva Surgical, says, “Our mission is to increase awareness of this common condition which affects 1 in 3 women and is the leading cause of hysterectomies. We know that our mothers, sisters, and wives don’t talk about the negative effects of their periods on their lives every month, and that needs to change.
Supporters can join the conversation using the hashtags #AUBAwareness and #TimeToTalkAUB. They are also encouraged to visit www.aubandme.com to understand the symptoms and causes and learn more about minimally invasive treatment options for abnormal uterine bleeding.
“Our website, www.aubandme.com, was developed as an educational tool for women to learn more about AUB and the treatment options available. This allows for a productive two-way conversation between a patient and her doctor, so she can choose the treatment that’s best for her. We encourage any woman living with AUB to talk to her doctor about her problematic periods,” Clapper concluded.
Minerva is attending the American College of Obstetrics and Gynecology (ACOG) Annual Meeting in San Diego, CA May 6-8, 2022 and invites attendees to visit booth 1821 to meet our team, learn more about the awareness day at AUB and the educational resources available. for them.
ABOUT MINERVA SURGICAL, INC. – THE UTERINE HEALTH SOCIETY
Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing and marketing minimally invasive solutions to meet the distinct uterine care needs of women. The company has introduced a wide range of commercially available products, minimally invasive alternatives to hysterectomy, designed to treat the most common causes of abnormal uterine bleeding (UAB) in most uterine anatomy. Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.
INVESTOR RELATIONS CONTACT: